Clinical Trials
4 trialsNCT05294900 2026-05-26
NEOS
Yonsei University
Phase 2 Completed
NCT06062602 2023-10-06
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT05992610 2023-08-15
iCHRTL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Unknown
NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed